Skip to main content

and
  1. Article

    Correction to: Allogeneic hematopoietic stem cell transplantation in elderly patients with acute myeloid leukemia or myelodysplastic syndromes: myth and reality

    A Correction to this paper has been published: https://doi.org/10.1038/s41375-020-01112-1.

    A. Sutra Del Galy, A. Marouf, E. Raffoux, M. Robin, D. Michonneau, M. Sébert in Leukemia (2021)

  2. No Access

    Article

    Allogeneic hematopoietic stem cell transplantation in elderly patients with acute myeloid leukemia or myelodysplastic syndromes: myth and reality

    A. Sutra Del Galy, A. Marouf, E. Raffoux, M. Robin, D. Michonneau, M. Sébert in Leukemia (2021)

  3. Article

    Open Access

    Validation of response assessment according to international consortium for MDS/MPN criteria in chronic myelomonocytic leukemia treated with hypomethylating agents

    M Duchmann, T Braun, J-B Micol, U Platzbecker, S Park, S Pilorge in Blood Cancer Journal (2017)

  4. No Access

    Article

    Equivalent outcomes using reduced intensity or conventional myeloablative conditioning transplantation for patients aged 35 years and over with AML

    Allogeneic hematopoietic stem cell transplantation provides the best chance of long-term survival for patients with AML, but is associated with an unpredictable risk of treatment-related mortality. From Januar...

    M Sébert, R Porcher, M Robin, L Adès, N Boissel, E Raffoux in Bone Marrow Transplantation (2015)